Importance of Temperature Monitoring During Clinical Trials
Temperature and humidity fluctuations can compromise the quality, safety, and efficacy of IMPs. Improper storage or transit conditions can render trial drugs ineffective or unsafe, threatening participant eligibility and jeopardizing the trial's outcomes.
By adhering to guidelines from organizations such as the NIH and submitting clinical study reports that meet transparency standards, sponsors demonstrate compliance and reinforce public trust in clinical research. Maintaining product integrity through effective temperature monitoring is particularly vital when trials address treatments for chronic diseases, where progress can have profound public health implications.
Stability Budgets in Clinical Trials
The stability budget is an essential part of the supply chain, defining acceptable time and temperature conditions during transit, storage, and handling. It ensures that IMPs retain their quality even when minor deviations occur during processes like packaging, loading, and transit. Using data loggers that continuously monitor the remaining stability budget ensures compliance with GDP and minimizes risks to product efficacy and patient safety.
Challenges in Temperature Monitoring
Temperature monitoring is increasingly complex due to the variety of devices and systems used, such as Bluetooth® Low Energy loggers, wireless networks, and USB stand-alone units. Since they access data differently and use various data formats, combining the said options into a single system is very complex. Idealistically, software that would be compatible with a variety of operating systems should easily merge different data formats and allow for analysis. Effective monitoring requires software that integrates data from various sources into a unified database. Compliance with guidelines like GAMP5 ensures data transparency and facilitates regulatory submission.
The Complexity of Temperature Monitoring
Temperature monitoring processes need to be compliant with GDP, MHRA, and GMP requirements throughout the phases of the clinical supply chain. The reason for compliance is to ensure patient safety. These requirements ensure the integrity of a product throughout its entire lifecycle. The difficulties in maintaining compliance are a result of a more complex process and numerous hand-over points. The manual process of compliance is not only expensive and time-consuming, it is also prone to error. Ultimately, it puts the quality of the product at risk.